Medical
7 May 2022
8:30 — 8:45
Green+Blue
Welcome address by BELNUC President
Green+Blue
9:00 — 10:30
Green+Blue
The role of PET in dementia
| Moderators: Koen Van Laere and Thierry Vander Borght | |
| 09:00 – 09:40 | Clinical PET in dementia : an update on FDG and amyloid Prof. Eric Salmon (BE) |
| 09:40 – 10:10 | Advances in tau imaging : ready for clinical use ? Prof. Alexander Drzezga (DE) |
| 10:10 – 10:30 | Synaptic density in dementia : a better marker than FDG ? Prof. Koen Van Laere (BE) |
Green+Blue
10:30 — 11:00
Hall 4
Coffee break
Hall 4
11:00 — 12:00
Green+Blue
Proffered papers
| Moderators: Géraldine Gebhart and Tim Van den Wyngaert | |
| 11:00 – 11:10 | [18F]AlF-NOTA-octreotide vs. [68Ga]Ga-DOTA-somatostatin analogue PET in neuroendocrine tumour patients: interim results of a prospective multicentre trial Elin Pauwels (UZ Leuven, Leuven) |
| 11:10 – 11:20 | Yttrium-90 radioembolization versus drug-eluting beads chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE trial Bieke Lambert (UGent, Gent) |
| 11:20 – 11:30 | Comparison between Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE and external beam radiation therapy Wendy Delbart (Institut Jules Bordet, Anderlecht) |
| 11:30 – 11:40 | 3p-C-NETA-TATE: A versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals Stephen Ahenkorah (SCK CEN, Mol) |
| 11:40 – 11:50 | Disturbing the redox balance as a new radiosensitizing strategy for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Wendy Delbart (Institut Jules Bordet, Anderlecht) |
| 11:50 – 12:00 | Bone SPECT/CT for assessing persistent or recurrent pain post spondylodesis: a retrospective study and pattern analysis Bieke Lambert (AZ Maria Middelares, Gent) |
Green+Blue
12:00 — 13:00
Hall 4
Lunch break + posters
Hall 4
13:00 — 14:00
Green+Blue
Interactive session: Reimbursement of radionuclide therapies in Belgium: Update on BELNUC proposal and round table discussion
Green+Blue
14:00 — 15:30
Green+Blue
Upcoming technologies
| Moderators: Cédric Reichel and Nadia Withofs | |
| 14:00 – 14:45 | Is total body PET/CT here to stay? An investigation into clinical applications of a new imaging technique Prof. Stefaan Vandenberghe (BE) |
| 14:45 – 15:30 | What to expect from annular SPECT/CT. A clinical center’s opinion. Dr. Matthieu Bailly (FR) |
Green+Blue
15:30 — 16:00
Hall 4
Coffee break
Hall 4
16:00 — 17:20
Green+Blue
Young nuclearist challenge
| Moderators: Félicie Sherer and Sander Jentjens | |
| 16:00 – 16:10 | The nerve-racking case of [18F]PSMA-1007 PET/CT in a patient with continuous low back pain Anne-Leen Deleu (UZ Leuven, Leuven) |
| 16:10 – 16:20 | Breaking the oculo-(para)neoplastic reflex on FDG-PET/CT: cerebellar hypermetabolism in a Hodgkin lymphoma leads to an unexpected diagnosis Eef Vanerwegen (Imelda Hospital, Bonheiden) |
| 16:20 – 16:30 | “Looks like the raccoon sign…” “Baboon?” “No, RACCOON!!!” Lynn De Mey (UZ Brussel, Brussels) |
| 16:30 – 16:40 | Just a little RE(nal)SPECT Geraldine Lens (UZ Leuven, Leuven) |
| 16:40 – 16:50 | Progestin-associated meningiomas: raising awareness about a causal oncological association Amélie Castiaux (Institut Jules Bordet, Anderlecht) |
| 16:50 – 17:00 | Idiopathic SIADH: 4 years of diagnostic wandering Omar Mzaiti (CHU Liège, Liège) |
| 17:00 – 17:10 | 18F-FDG PET/CT unveils a cyst with a twist Pieter Claes (Ziekenhuis Oost-Limburg, Genk) |
| 17:10 – 17:20 | Femoral osteonecrosis in the setting of myelodysplastic syndrome with blasts excess Isaac Kargar Samani (CHU UCL Namur – Site Godinne, Yvoir) |
Green+Blue
Pharmacy break-out sessions
7 May 2022
11:00 — 12:00
Orange
GMP, quality and regulations + proffered papers
| Moderators: Filip De Vos and Dominique Vanderghinste | |
| 11:00 – 11:25 | Implementing the PIC/S guide in nuclear medicine: a practical guidance Prof. Filip De Vos (BE) and Apr. Caroline Vermeiren (BE) |
| Selected abstracts: | |
| 11:25 – 11:36 | Development and evaluation of a trans-cyclooctene (TCO) probe for pretargeted PET imaging Karuna Adhikari (University of Antwerp, Antwerp) |
| 11:36 – 11:47 | Site-specific conjugation of fluorescent dyes and chelators on antibody fragments via maleimide-thiol chemistry Simon Leekens (Laboratory of Radiopharmaceutical Research KU Leuven, Leuven) |
| 11:47 – 12:00 | Development and in vitro evaluation of caspase-3-selective PET probes Louis Lauwerys (University of Antwerp, Antwerp) |
Orange
14:00 — 15:30
Orange
F-18 and C-11 chemistry + proffered papers
| Moderators: Guy Bormans and Simon Lacroix | |
| 14:00 – 14:50 | Prosthetic group-based 18F labelling of peptides and proteins Dr. Térence Tshibangu Tshikondu Tshiamalu (BE) |
| Selected abstracts: | |
| 14:50 – 15:03 | Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging Herlinde Dierick (Vrije Universiteit Brussel (VUB), Brussels) |
| 15:03 – 15:16 | Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression Romy Cools (Laboratory for Radiopharmaceutical Research KU Leuven, Leuven) |
| 15:16 – 15:30 | Second generation Al18F-labeled D-amino acid based peptide for CXCR4 targeted molecular imaging Spahn Muriel (KU Leuven, Leuven) |
Orange
16:00 — 17:20
Orange
Theranostics + proffered papers
| Moderators: Vicky Caveliers and Zena Wimana | |
| 16:00 – 16:30 | Theranostic radiopharmaceuticals: where are we now? Prof. Rudolf Werner (DE) |
| 16:30 – 17:00 | Recent advances in chelators for alpha emitters Dr. Sophie Poty (FR) |
| Selected abstracts: | |
| 17:00 – 17:10 | RANKL immunoPET using 64Cu radiolabeled antibody Fab fragments to improve imaging characteristics Jonatan Dewulf (University of Antwerp, Antwerp) |
| 17:10 – 17:20 | Using the site-specific radiolabeling of a PD-L1 nanobody via maleimide–cysteine chemistry to develop a PET-tracer as screening tool for personalized oncology treatment Dora Mugoli Chigoho (Vrije Universiteit Brussel, Brussels) |
Orange
Physics break-out sessions
7 May 2022
11:00 — 12:00
Yellow
AI: from hype to medical physics?
| Moderators: Stefaan Vandenberghe | |
| 11:00 – 11:30 | AI in medical imaging Prof. Erik Ranschaert (BE) |
| 11:30 – 12:00 | AI in nuclear medicine Prof. Dimitris Visvikis (FR) |
Yellow
14:00 — 15:30
Yellow
Applications of AI in nuclear medicine
| Moderators: Michel Koole and Stijn De Schepper | |
| 14:00 – 14:30 | Starting an AI project Zelda Paquier (BE) |
| 14:30 – 15:00 | Image reconstruction Dr. Georg Schramm (BE) |
| 15:00 – 15:30 | Radiomics Dr. Fanny Orlhac (FR) |
Yellow
16:00 — 17:20
Yellow
Isotopes of the future + proffered papers
| Moderators: Claire Bernard and Bruno Vanderlinden | |
| 16:00 – 16:30 | Isotopes of the future Prof. Thomas Elias Cocolios (BE) |
| Selected abstracts: | |
| 16:30 – 16:40 | Dosimetric model for patients with renal failure undergoing dialysis during I-131 therapy for thyroid cancer Victor Nuttens (OLV Aalst, Aalst) |
| 16:40 – 16:50 | Development of an anthropomorphic phantom for mandibular condyle imaging Stijn De Schepper (UZA, Antwerpen) |
| 16:50 – 17:00 | Feasibility of lesion dosimetry assuming constant pharmacokinetics over cycles in patients treated with 177Lu-DOTATATE Rachele Danieli (Institut Jules Bordet, Anderlecht) |
| 17:00 – 17:10 | Radiation dose optimization of CT acquisitions in SPECT/CT examinations Lauren Podevyn (UGent, Ghent) |
| 17:10 – 17:20 | StarGuide Tc-99m imaging reconstruction parameters optimization Jirair Karabet (Institut Jules Bordet, Anderlecht) |
Yellow
Technologist break-out sessions
7 May 2022
9:00 — 10:30
Red+purple
Clinical update
| Moderators: Sara Vieira and Kim Van Hullebusch | |
| 09:00 – 09:45 | Cardiac PET: patient preparation, acquisition, and clinical applications Prof. Olivier Gheysens (BE) |
| 09:45 – 10:30 | Nuclear medicine in endocrinology: an update Dr. Duran Derijckere (BE) |
Red+purple
11:00 — 12:00
Red+purple
Clinical management
| Moderators: Christelle Terwinghe and Geraldine Vandermeiren | |
| 11:00 – 11:30 | Paediatric Patient care – Technologist practice improvement Mrs. Andrea Santos (PT) |
| 11:30 – 12:00 | Patient communication Mrs. Hanne Kindermans (BE) |
Red+purple
14:00 — 15:30
Red+purple
Radionuclide therapy
| Moderators: Nele Eecloo and Wouter Daenen | |
| 14:00 – 14:45 | Calibration of non-imaging instrumentation Prof. Kristof Baete (BE) |
| 14:45 – 15:30 | Apha emitters: current and future applications Dr. Maarten Ooms (BE) |
Red+purple
16:00 — 17:20
Red+purple
FANC session + Proffered papers
| Moderators: Jean-Paul Thys and Filip Lavent | |
| 16:00 – 16:30 | Radionuclide therapy waste management Mrs. Jolien Berlamont (BE) |
| Selected abstracts: | |
| 16:30 – 16:42 | Logistical analysis of the individual “whole body” dosimetry of personnel professionally exposed to ionizing radiation in Belgium, over the last 10 years Ana Mafalda Pereira Gomes (Vinçotte S.A, Vilvoorde) |
| 16:42 – 16:54 | Design of an integrated Radiopharmaceutical Supply Chain (SC) to enhance its overall Supply Chain Performance Methodology Rabarijaona Haingo (Université Libre de Bruxelles, Brussels) |
| 16:54 – 17:06 | Can a third party software vendor (MIMVista) match the image quality of native software vendor? Bram Van Landeghem (AZ Jan Palfijn Gent, Ghent) |
| 17:06 – 17:20 | Implementing Lutetium-177 PSMA ligand therapy: practical aspects concerning radioprotection and dosimetry Nico Dhondt (AZ Maria Middelares, Ghent) |
Red+purple
Medical
8 May 2022
9:00 — 10:00
Green+Blue
Clinical state of PET/MR
| Moderators: Koen Van Laere and Vanessa Schelfhout | |
| 09:00 – 09:30 | PET/MRI in brain imaging Prof. Ian Law (DK) |
| 09:30 – 10:00 | PET/MRI in oncology Prof. Irene Burger (CH) |
Green+Blue
10:00 — 10:30
Hall 4
Coffee break
Hall 4
10:30 — 12:15
Green+Blue
Are we ready for artificial intelligence?
| Moderators: Patrick Flamen and Anne Delcourt | |
| 10:30 – 10:55 | The technical and methodological aspects of AI Prof. Irene Buvat (FR) |
| 10:55 – 11:20 | Medical applications of AI with focus on (nuclear) imaging Prof. Henry Woodruff (NL) |
| 11:20 – 12:00 | The ethical and legal aspects of AI in healthcare Prof. Tom Goffin (BE) |
Green+Blue
The BELNUC ’22 symposium is accredited for:
- RIZIV/INAMI 6.5 CP (category 3 – National Meeting; n° 22000499)
- RIZIV/INAMI 3.0 CP (category 6 – Ethics & Economy; n° 22000501)
- FANC/AFCN radiation protection
- 5h nuclear medicine physicians
- 1h nuclear medicine physicians RX
- 2.5h radiopharmacists
- 3h physicists (nuclear medicine)
- 3h agents/technologists (nuclear medicine)
- Federal Public Service: Health, Food Chain Safety, and Environment, Hospital pharmacists (modules 4 and 5; requested)